Good day, and welcome to the Acme United Corporation's second quarter 2025 financial results conference call. At this time, I would like to turn the call over to Walter Johnsen, Chairman and CEO. Please go ahead, sir. Good morning. Welcome to the second quarter 2025 earnings conference call for Acme United Corporation. I am Walter C. Johnsen, Chairman and CEO. With me is Paul Driscoll, our Chief Financial Officer, who will first read a safe harbor statement. Paul? Forward-looking statements in this conference call, including without limitation, statements related to the company's plan, strategies, objectives, expectations, intentions, and adequacy of capital and other resources are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, among others, those arising as a result of a challenging global macroeconomic environment characterized by continued high inflation, high interest rates, and the imposition of new tariffs or changes in existing tariff rates. In addition, we have experienced supply chain disruptions, and we may experience these disruptions in the future. We are also subject to additional risks and uncertainties as described in our periodic filings with the Securities and Exchange Commission and in our current earnings release. Thank you, Paul. Acme United had an excellent second quarter of 2025, setting a quarterly record for earnings. This, of course, excludes the one-time gains from the forgiveness of the PPP loan in 2021 and the sale of the Cuda and Camillus businesses in 2023. Our net sales in the quarter were $54 million, compared to $55.4 million in 2025. Net income in the quarter was $4.8 million, compared to $4.5 million, and earnings per share were $1.16 versus $1.09. The market environment was particularly challenging due to tariffs. As you may remember, our last 10 acquisitions have been manufacturers in the United States and Canada, so our reliance on imported items is much less than some of our competitors. When tariffs on goods imported from China were raised to 145%, our customers who planned to directly import our products canceled their orders that were scheduled to ship. They appear to have determined that using existing stocks, substituting items, or even having empty shelves were more attractive than losing money on the products. They canceled and delayed orders, which reduced our sales. Acme had built extra inventory during late 2024 and early 2025. We were prepared for the tariffs, but we did not anticipate tariffs as high as 145%. We too stopped importing items to the United States, but we continued producing and storing the finished goods at our factories in China. We supplied our regular Westcott customers from domestic inventory and tried to help when they ran out of private label products. However, we did not accept large, unplanned orders, which would have reduced our ability to meet regular customer requirements. We worked with our suppliers to reduce costs, took advantage of operating efficiencies, and increased our selling prices moderately. Our products that we import are currently priced appropriately for the present 30% tariff on Chinese goods. We're also shifting production from China to other locations, including Malaysia, Thailand, Vietnam, Egypt, and our own factories. We intend to continue to supply our customers with the best total costs, including tariffs, and to maintain excellent service. Our factories in the United States have benefited from the increased tariffs. Our Med-Nap facility in Brooksville, Florida, is producing alcohol and BZK wipes, castile soap, and other first aid items at record levels. Our Vancouver, Washington, and Rocky Mount, North Carolina plants that produce first aid kits are running at full speed. Our Spill Magic spill cleanup plants in Santa Ana, California, and Smyrna, Tennessee, are running multiple shifts. Last week, we purchased a new facility for Spill Magic in Mount Pleasant, Tennessee, for approximately $6 million. The plant is 77,000 sq ft on 12 acres and has room for expansion. We start production there in the first quarter of 2026. While the second quarter was very challenging, I would like to thank our team for managing the tariff disruptions, working with our customers to meet their supply requirements, and executing well. They turned a challenge into an opportunity. As we look at the rest of the year, we anticipate growth and continued earnings strength. We believe there will be opportunity to gain share in the Westcott cutting tools and our first aid business, particularly in the retail and industrial markets, due to our low total costs and supply chain diversification. I will now turn the call to Paul. Corporation's net sales for the second quarter were $54 million, compared to $55.4 million in 2024, a decrease of 3%. Sales for the six months ended June 30th, 2025, were $100 million, compared to $100.4 million in the same period in 2024. Net sales in the U.S. segment decreased 6% in the second quarter due to the cancellation of some back-to-school customer orders as a result of exceptionally high tariffs in April and May. Additionally, there was a large initial order of new kitchen sharpeners to a major mass market retailer that took place in the second quarter of 2024. Sales decreased 2% for the six months ended June 30th. Net sales in Europe decreased 6% in local currency for the quarter and 6% for the six months ending June 30th. The sales decrease for both periods was mainly due to the timing of shipments. We expect growth in the third quarter. Net sales in local currency for Canada increased 28% in the quarter and 21% for the year-to-date, mainly due to higher sales of First Aid products. The gross margin was 41% in the second quarter of 2025 and 2024. Gross margin was 40% for the first six months of 2024 and 2025. SG&A expenses for the second quarter of 2025 were $15.8 million, or 29% of sales, compared with $16.3 million, or 29% of sales for the same period of 2024. The lower SG&A in the quarter was due to cost savings and reduced discretionary spending. SG&A expenses for the first six months of 2025 were $31.3 million, or 31% of sales, compared with $31.1 million, or 31% of sales in 2024. Net income for the second quarter of 2025 was $4.8 million, or $1.16 per diluted share, compared to a net income of $4.5 million, or $1.09 per diluted share for the same period of 2024, an increase of 7% in net income and 6% in earnings per share. Net income for the first six months ended June 30th, 2025, was $6.4 million, or $1.57 per diluted share, compared to $6.1 million, or $1.47 per diluted share in the comparable period last year, increases of 5% and 7%. The company's bank debt, less cash, on June 30th, 2025, was $23 million, compared to $33 million on June 30th, 2024. During a 12-month period, we paid $2.8 million in dividends and generated approximately $12 million in free cash flow. Thank you, Paul. I will now open the call to questions. Thank you. We'll now be conducting a question and answer session. If you would like to ask a question, please press star one on your telephone keypad. A confirmation tone will indicate your line is in the question queue. You may press star two to remove your question from the queue. For participants using speaker equipment, it may be necessary to pick up your handset before pressing the star keys. Our first question is from Jim Marrone with Singular Research. Good afternoon, gentlemen. Job well done on the supply management and working the inventory in your supply chains. I would imagine that resulted in a small decrease in the top line of 3% and an increase in your net income as a result. My question then is, if the results were tempered as a result of the inventory management and your other cost strategies, what can you expect going forward for the third and fourth quarter? You said that you anticipate growth, but can you provide any quantitative guidance? Do you expect a revenue decrease as well as earnings decrease for the third quarter and fourth quarter? I'll anticipate your answer, and then I'll have a follow-up question after that. Jim, that's a very good question. There were a number of programs that were delayed in the second quarter because the customers, frankly, did not want to import them at 145% tariff and then lose money. Some of them will probably come into the third and fourth quarters as the inventory that's currently on hand is used up. It is a very tricky thing because during that period, many retailers and all of the buyers were focused on one thing: get me product, get it cheap, what price, and where. The last thing they were thinking about was what will they sell in October, November, December. It was a scramble for here and now. You may remember that many customers were shipping to bonded warehouses, shipping to Canada, going to places that you'd never dream of, in order to hold stock. We did some of that. It was in many ways chaotic for our customers, particularly because they have planned programs that are slotted. Some of them, when they canceled, don't get repeated. We also have a concern about demand, not for our products. I don't think our prices were particularly aggressively increased because we had other ways to offset price. In general, there's something of a price increase across the board for many items, and it may reduce some customer spending. We don't know that. What we do know is that we have adequate stock at good values today. We're working with our customers on recovering programs that were delayed. We're looking for growth in the third and fourth quarters, not declines, growth in sales. Again, we can't forecast what actually happens with demand, but so far, we haven't seen a big falloff. I hope that helped a little bit. Yeah, no, that'll provide some visibility. Are you hearing anything from your competitors, your peers? Are they faring better or are they faring worse? Maybe if you can also talk about other strategies, is potentially cutting the dividend a possibility? I look forward to hearing your answer to that. We just raised our dividend, and we just generated $12 million of free cash flow in the last 12 months, which was a record. The dividend we're very comfortable with, and frankly, our debt is at $22 million. It's down $11 million from $33 million. It's down $11 million in the past six months. The dividend we're fully expected to continue, and the cash flow and the company's performance supports that. Relative to other competitors, one competitor had a disastrous quarter, and I don't know what they were doing or why they were doing it, but it was a complete disaster. We'll be able to see more in the coming weeks, but I can tell you that we did a good job, and we anticipated the tariffs, and we managed our customers as well as we thought we could do. Others apparently did not. Yeah, thank you for your answers, gentlemen. Thanks, Jim. Our next question is from Tim Call with Capital Management Corporation. Congratulations on a strong quarter. Thanks, Tim. I know that the free cash flow pays down debt and lowers interest expense over time, but if the Federal Reserve lowers interest rates later this year, does that also help lower your interest expense? Oh, sure. Yeah. About $10.4 million of fixed mortgage, that's on our Vancouver, Washington property and our Rocky Mount, North Carolina property. Paul, is that at 3.4% fixed? It's 3.8%. 3.8%. $10.3 million is fixed. The remaining piece floats, and that would be a benefit to us if rates were to drop. Great. With the capacity constraints you've had in Spill Magic from growing it, it's good to hear you found a way to expand that capacity a great deal in the near future. Sometimes you have similar issues with certain healthcare lines. Are you experiencing that anywhere in healthcare? Are you increasing productivity or expanding capacity in any of those areas? In the Med-Nap facility in Florida, our revenues are up substantially, and they clearly are stressed. We're running two shifts, and we're working on new products and a lot of productivity improvements there. In the short term, we're doing things like buying portable trailers to move the office out of an area that we turned into production. We expanded our microbial lab by buying another portable trailer. Eventually, we'd like to get a permanent home that's larger in Florida for the Med-Nap business. Med-Nap also, because it's a supplier of alcohol wipes and BZK wipes and alcohol prep pads, is pretty critical in the U.S. medical industry, including the hospital area where we think we have some real growth potential. We have been buying major new pieces of equipment, including automation, to not only drive our costs down but get more consistency in the product. We're also making major investments in documentation in Med-Nap and training in preparation for what we hope is some business in the future with the hospital market at Med-Nap. Relative to Spill Magic, this facility that we bought gives it a permanent home, and there's a very big difference between a leased manufacturing facility where you never know when you'll have a big price increase and you've got to move equipment. Over time, as you build out a factory, that equipment becomes, hopefully, bigger and better and, unfortunately, less mobile. By buying the facility in Mount Pleasant, and I will be in Mount Pleasant tomorrow working on that project, we're really laying the groundwork for substantial material flow automation, packaging automation, and we're excited because we know we can drive productivity when we have our own facility and are able to make permanent installations. In other sites, for example, our Vancouver, Washington facility, we would love to expand, but the real estate values in Vancouver, Washington, which is just across the border from Portland, are very high. Although we've looked for a number of years to expand the facility, to date, we haven't found an attractive enough value to allocate assets there as opposed to elsewhere in the company. Our Rocky Mount, North Carolina facility gained capacity in storage when we did the installation of new racking during the first six months of this year, and that's increased it by about a third. We've recently installed automation there for packing bulk items into boxes for the medical business. I would expect similar kinds of automation in Vancouver, Washington, and perhaps in our facility in Canada at First Aid Central. As you may know, we doubled the space at First Aid Central during the past 12 months, and the business is growing and filling it very nicely. The constraints on space, we're managing, I think, adequately, perhaps well. The capital spending program continues to get more exciting because as we're generating savings, we're generating more cash to reinvest in more and stronger automation. I'm excited about that. That sounds good. Congratulations again. Thanks, Tim. Our next question is from Georgy Vashchenko with Freedom Broker. I'm going to have to know. Could you please highlight which segment was mostly hurt by the tariff increase, first aid or cutting and sharpening? Thank you. The first aid business tends to be more regularly ordered by industrial accounts and retail accounts. The Westcott cutting tool area has some seasons, for example, back-to-school. When orders were canceled and programs were canceled in April and May, that directly impacted Westcott because those products that we would have shipped for sale for back-to-school were no longer going to be available, just canceled. It was the Westcott side that was hit more significantly. Also, on price increases, the first aid area, because we've got more of a production base in the United States and in Canada, we're able to be a lot more moderate in our price increases. Although we got productivity improvements and we did a lot of good things in Westcott, the volumes there were impacted more. Of course, the recovery will probably be stronger in Westcott because as the stocks run down with the retailers, assuming demand continues, they'll be buying. Oh, thank you. That's helpful. Thank you. There are no further questions. Okay. I'd just like to turn it over to Walter Johnsen. All right. Thank you very much. If there are no further questions, this call is complete. I would like to thank you for joining us, and we look forward to delivering the best results we can in the coming quarters. Goodbye.